UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
Key Details
- 1The AI leverages semi-supervised positive unlabeled learning to identify probable Alzheimer's cases from electronic health records (EHRs).
- 2Tested on data from over 97,000 UCLA Health patients across multiple ethnic groups.
- 3Achieved 77–81% sensitivity in various populations compared to 39–53% for traditional models.
- 4Model validation included polygenic risk scores (APOE ε4 allele), supporting accuracy of predictions.
- 5Tool addresses underdiagnosis, which especially affects African American and Hispanic/Latino communities.
- 6Planned prospective validation in other health systems; patent application filed for framework.
Why It Matters
AI-driven detection of undiagnosed Alzheimer's may support earlier intervention, which is critical as new treatments emerge. Importantly, this model addresses equity concerns by reducing diagnostic bias across diverse populations, a key consideration for both clinical and AI application in healthcare.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.